Singapore markets closed

RLMD Nov 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.55000.0000 (0.00%)
As of 11:51AM EDT. Market open.
Full screen
Previous close1.5500
Open1.5500
Bid0.0000
Ask0.0000
Strike2.50
Expiry date2024-11-15
Day's range1.5500 - 1.5500
Contract rangeN/A
Volume1
Open interest116
  • PR Newswire

    Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer, will participate in a fireside chat at the 2024 Goldman Sachs Global Healthcare Conference in Miami, Florida on Wednesday, June 12, 2024, at 11:20am ET. Management will also host one-on-one investor meetings. Please find additional details about the event below.

  • PR Newswire

    Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference

    Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in a fireside chat on Thursday, June 6, 2024, at 7:30am ET at the 2024 Jefferies Global Healthcare Conference in New York, NY. Management will also host one-on-one investor meetings. Please find additional details about the event below.

  • Insider Monkey

    Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript

    Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript May 10, 2024 Relmada Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). LifeSci Advisors: Sergio Traversa – Chief Executive Officer Maged Shenouda – Chief Financial Officer Andrew Cutler – Senior […]